Phase II Trial of Sorafenib in Conjunction With Chemotherapy and as Maintenance Therapy in Extensive-Stage Small Cell Lung Cancer.
Phase of Trial: Phase II
Latest Information Update: 15 Jan 2014
At a glance
- Drugs Sorafenib (Primary) ; Cisplatin; Etoposide
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 14 Nov 2012 Planned end date changed from 1 Jun 2012 to 1 Aug 2012 as reported by ClinicalTrials.gov.
- 01 Jul 2012 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 22 Nov 2011 Status changed from suspended to active, no longer recruiting as reported by ClinicalTrials.gov.